Document is current
Any future updates will be listed below
-
Authors
Soehnlein, Oliver https://orcid.org/0000-0002-7854-0694
Tall, Alan R. https://orcid.org/0000-0002-7708-2417
- License Information
-
More Information
Article History
First Online: 26 July 2022
Competing interests
: O.S. holds patents on neutralization of histones and interference with chemokines in inflammation; receives funding from Novo Nordisk to study the role of histones in inflammation and to study chronopharmacological intervention strategies in atherosclerosis; and is on the scientific advisory board of ResoTher. A.R.T. is on the scientific advisory board of Tensixteen Bio and Beren Pharmaceuticals and is a consultant for Commonwealth Serum Laboratories.
